JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB197012

Cathepsin L Inhibitor Assay Kit (Fluorometric)

Be the first to review this product! Submit a review

|

(7 Publications)

Cathepsin L Inhibitor Screening Kit (Fluorometric) (197012) is an assay that uses the ability of active Cathepsin L to cleave the synthetic AFC-based peptide substrate to release AFC, which can be easily quantified using a fluorometer or fluorescence microplate reader.

View Alternative Names

CTSL1, CTSL, Procathepsin L, Cathepsin L1, Major excreted protein, MEP

1 Images
Functional Studies - Cathepsin L Inhibitor Assay Kit (Fluorometric) (AB197012)
  • FuncS

Supplier Data

Functional Studies - Cathepsin L Inhibitor Assay Kit (Fluorometric) (AB197012)

Inhibition of Cathepsin L activity by Cathepsin L inhibitor.

Inhibition of Cathepsin L activity using CTSL (cathepsin L inhibitor) provided in the kit. Assay was performed following the kit protocol.

Key facts

Detection method

Fluorescent

Sample types

Inhibitor compounds

Results type

Quantitative

Assay Platform

Microplate reader

Product details

Cathepsin L Inhibitor Screening Kit (Fluorometric) (197012) is an assay that uses the ability of active Cathepsin L to cleave the synthetic AFC-based peptide substrate to release AFC, which can be easily quantified using a fluorometer or fluorescence microplate reader. In the presence of a Cathepsin L inhibitor, the cleavage of this substrate is reduced/abolished resulting in decrease or total loss of the AFC fluorescence. This simple and high-throughput adaptable assay kit can be used to screen/study/characterize potential inhibitors of Cathepsin L.

This product is manufactured by BioVision, an Abcam company and was previously called K161 Cathepsin L Inhibitor Screening Kit (Fluorometric). K161-100 is the same size as the 100 test size of ab197012.

Cathepsin L (CTSL, EC 3.4.22.15) is a lysosomal cysteine protease that is implicated in protein degradation, arthritis, apoptosis, and cancer. Cathepsin L plays a major role in antigen processing, tumor invasion and metastasis, bone resorption, and turnover of intracellular and secreted proteins involved in growth regulation. Although commonly recognized as a lysosomal protease, cathepsin L is also secreted. This broad-spectrum protease is potent in degrading several extracellular proteins (laminins, fibronectin, collagens I and IV, elastin, and other structural proteins of basement membranes) as well as serum proteins and cytoplasmic and nuclear proteins.

The Safety Datasheet for this product has been updated for certain countries. Please check the current version in the Support and downloads section.

What's included?

{ "values": { "100Test": { "sellingSize": "100 Test", "publicAssetCode":"ab197012-100Test", "assetComponentDetails": [ { "size":"1 x 0.1 mL", "name":"Cathepsin L Activator", "number":"AB197012-CMP03" }, { "size":"1 x 10 µL", "name":"Human Cathepsin L", "number":"AB197012-CMP05" }, { "size":"1 x 100 µL", "name":"DTT II", "number":"AB197012-CMP06" }, { "size":"1 x 25 mL", "name":"Cathepsin L Assay Buffer", "number":"AB197012-CMP02" }, { "size":"1 x 200 µL", "name":"Cathepsin L Substrate", "number":"AB197012-CMP04" }, { "size":"1 x 20 µL", "name":"Cathepsin Inhibitor", "number":"AB197012-CMP01" } ] }, "100Test": { "sellingSize": "100 Test", "publicAssetCode":"ab197012-100Test", "assetComponentDetails": [ { "size":"1 x 10 µL", "name":"Human Cathepsin L", "number":"AB197012-CMP05", "productcode":"" }, { "size":"1 x 200 µL", "name":"Cathepsin L Substrate", "number":"AB197012-CMP04", "productcode":"" }, { "size":"1 x 15 mL", "name":"Cathepsin L Assay Buffer", "number":"AB197012-CMP02", "productcode":"" }, { "size":"1 x 0.1 mL", "name":"Cathepsin L Activator", "number":"AB197012-CMP03", "productcode":"" }, { "size":"1 x 100 µL", "name":"DTT II", "number":"AB197012-CMP06", "productcode":"" }, { "size":"1 x 20 µL", "name":"Cathepsin Inhibitor", "number":"AB197012-CMP01", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Storage information
Please refer to protocols

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cathepsin L also known as major excreted protein (MEP) or EC 3.4.22.15 is a critical cysteine protease with a molecular weight of approximately 30-40 kDa. It performs proteolytic functions within the lysosomes executing the breakdown of proteins into peptides. This protease expresses prominently in various tissues including liver kidney spleen and lungs where it fulfills tasks integral to cellular maintenance and turnover.
Biological function summary

This protease contributes to antigen processing and the degradation of intracellular proteins. Cathepsin L participates in essential processes such as protein catabolism and the remodeling of the extracellular matrix. Although it is not part of a large protein complex its enzymatic activity influences multiple cellular functions making it an active agent in maintaining cellular homeostasis.

Pathways

Cathepsin L takes part in the antigen processing and presentation pathway contributing to immune system functions. It also associates with the lysosomal pathway for protein degradation interacting with other cathepsins such as Cathepsin B and Cathepsin D. These pathways place it centrally in maintaining protein balance within cells and its activity can affect various downstream cellular processes.

Cathepsin L has associations with cancer and neurodegenerative disorders. Its overexpression can lead to increased invasiveness and metastasis in various cancers due to enhanced proteolytic activity. It also relates to Alzheimer's disease where abnormal protease function can disrupt the processing of amyloid precursor protein contributing to amyloid beta aggregation. In these conditions cathepsin L functions in concert with proteins like Cathepsin B linking it to pathological processes.

Product protocols

Target data

Thiol protease important for the overall degradation of proteins in lysosomes (Probable). Plays a critical for normal cellular functions such as general protein turnover, antigen processing and bone remodeling. Involved in the solubilization of cross-linked TG/thyroglobulin and in the subsequent release of thyroid hormone thyroxine (T4) by limited proteolysis of TG/thyroglobulin in the thyroid follicle lumen (By similarity). In neuroendocrine chromaffin cells secretory vesicles, catalyzes the prohormone proenkephalin processing to the active enkephalin peptide neurotransmitter (By similarity). In thymus, regulates CD4(+) T cell positive selection by generating the major histocompatibility complex class II (MHCII) bound peptide ligands presented by cortical thymic epithelial cells. Also mediates invariant chain processing in cortical thymic epithelial cells (By similarity). Major elastin-degrading enzyme at neutral pH. Accumulates as a mature and active enzyme in the extracellular space of antigen presenting cells (APCs) to regulate degradation of the extracellular matrix in the course of inflammation (By similarity). Secreted form generates endostatin from COL18A1 (PubMed : 10716919). Critical for cardiac morphology and function. Plays an important role in hair follicle morphogenesis and cycling, as well as epidermal differentiation (By similarity). Required for maximal stimulation of steroidogenesis by TIMP1 (By similarity).. (Microbial infection) In cells lacking TMPRSS2 expression, facilitates human coronaviruses SARS-CoV and SARS-CoV-2 infections via a slow acid-activated route with the proteolysis of coronavirus spike (S) glycoproteins in lysosome for entry into host cell (PubMed : 16339146, PubMed : 18562523, PubMed : 32142651, PubMed : 32221306, PubMed : 37990007). Proteolysis within lysosomes is sufficient to activate membrane fusion by coronaviruses SARS-CoV and EMC (HCoV-EMC) S as well as Zaire ebolavirus glycoproteins (PubMed : 16081529, PubMed : 18562523, PubMed : 26953343).. Isoform 2. Functions in the regulation of cell cycle progression through proteolytic processing of the CUX1 transcription factor (PubMed : 15099520). Translation initiation at downstream start sites allows the synthesis of isoforms that are devoid of a signal peptide and localize to the nucleus where they cleave the CUX1 transcription factor and modify its DNA binding properties (PubMed : 15099520).
See full target information CTSL

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

BMC veterinary research 21:377 PubMed40426227

2025

Host susceptibilities and entry processes of SARS-CoV-2 Omicron variants using pseudotyped viruses carrying spike protein.

Applications

Unspecified application

Species

Unspecified reactive species

Alexandria Zabiegala,Yunjeong Kim,Kyeong-Ok Chang

PNAS nexus 4:pgae578 PubMed39831159

2025

An orally available P1'-5-fluorinated M inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

Applications

Unspecified application

Species

Unspecified reactive species

Nobuyo Higashi-Kuwata,Haydar Bulut,Hironori Hayashi,Kohei Tsuji,Hiromi Ogata-Aoki,Maki Kiso,Nobutoki Takamune,Naoki Kishimoto,Shin-Ichiro Hattori,Takahiro Ishii,Takuya Kobayakawa,Kenta Nakano,Yukiko Shimizu,Debananda Das,Junji Saruwatari,Kazuya Hasegawa,Kazutaka Murayama,Yoshikazu Sukenaga,Yuki Takamatsu,Kazuhisa Yoshimura,Manabu Aoki,Yuri Furusawa,Tadashi Okamura,Seiya Yamayoshi,Yoshihiro Kawaoka,Shogo Misumi,Hirokazu Tamamura,Hiroaki Mitsuya

Nature communications 14:1076 PubMed36841831

2023

Identification of SARS-CoV-2 M inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.

Applications

Unspecified application

Species

Unspecified reactive species

Nobuyo Higashi-Kuwata,Kohei Tsuji,Hironori Hayashi,Haydar Bulut,Maki Kiso,Masaki Imai,Hiromi Ogata-Aoki,Takahiro Ishii,Takuya Kobayakawa,Kenta Nakano,Nobutoki Takamune,Naoki Kishimoto,Shin-Ichiro Hattori,Debananda Das,Yukari Uemura,Yosuke Shimizu,Manabu Aoki,Kazuya Hasegawa,Satoshi Suzuki,Akie Nishiyama,Junji Saruwatari,Yukiko Shimizu,Yoshikazu Sukenaga,Yuki Takamatsu,Kiyoto Tsuchiya,Kenji Maeda,Kazuhisa Yoshimura,Shun Iida,Seiya Ozono,Tadaki Suzuki,Tadashi Okamura,Shogo Misumi,Yoshihiro Kawaoka,Hirokazu Tamamura,Hiroaki Mitsuya

European journal of medicinal chemistry 244:114803 PubMed36209629

2022

Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen.

Applications

Unspecified application

Species

Unspecified reactive species

Liying Wang,Zhongtian Yu,Shiwei Wang,Zheng Guo,Qi Sun,Luhua Lai

European journal of medicinal chemistry 238:114508 PubMed35688005

2022

Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaodong Dou,Qi Sun,Guofeng Xu,Yameng Liu,Caifang Zhang,Bingding Wang,Yangbin Lu,Zheng Guo,Lingyu Su,Tongyu Huo,Xinyi Zhao,Chen Wang,Zhongtian Yu,Song Song,Liangren Zhang,Zhenming Liu,Luhua Lai,Ning Jiao

Theranostics 11:9821-9832 PubMed34815788

2021

CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoxun Li,Yajun Liang,Cheng Lian,Fangli Peng,Yansen Xiao,Yunfei He,Chengxin Ma,Yuan Wang,Peiyuan Zhang,Yuhan Deng,Yunpeng Su,Cheng Luo,Xiangyin Kong,Qingcheng Yang,Tong Liu,Guohong Hu

Biological & pharmaceutical bulletin 40:1240-1246 PubMed28502922

2017

Design, Synthesis, and Structure-Activity Relationship Study of Epoxysuccinyl-Peptide Derivatives as Cathepsin B Inhibitors.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoye Zhang,Xiaohong Yang,Hongqiang Wang,Song Li,Kun Guo,Dan Jiang,Junhai Xiao,Di Liang
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com